表紙
市場調查報告書
商品編碼
1035775

品牌仿製藥的全球市場分析:產業分析,市場規模·佔有率·成長率·趨勢·預測 (2020年∼2027年)

Global Branded Generics Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2020 to 2027

出版日期: | 出版商: Value Market Research | 英文 142 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球品牌仿製藥的市場相關分析,提供產品概要和市場基本結構·最新形勢,主要的推動及阻礙市場要素,各治療用途·各類藥物·各劑型類型·各流通管道·各地區的市場趨勢預測,市場競爭環境,主要企業簡介等調查。

目錄

第1章 序論

第2章 摘要整理

第3章 品牌仿製藥:產業分析

  • 簡介:市場動態
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 產業趨勢
  • 波特的五力分析
  • 市場向心力分析

第4章 價值鏈分析

  • 價值鏈分析
  • 原料分析
  • 潛在的購買者一覽
  • 行銷流通管道

第5章 新型冠狀病毒感染疾病 (COVID-19) 感染擴大的影響分析

  • COVID-19感染擴大的影響分析
  • COVID-19生產·進口·出口·需求趨勢的影響分析
  • COVID-19前/COVID-19後的市場
  • COVID-19感染擴大的影響評估
  • COVID-19:微觀·宏觀要素分析

第6章 全球品牌仿製藥市場:各治療用途

  • 市場概要:各治療用途
  • 市場趨勢,實際成果值·預測值
  • 各治療用途的市場分析
  • 腫瘤
  • 心血管疾病
  • 糖尿病
  • 神經疾病
  • 腸胃疾病
  • 皮膚科疾病
  • 止痛藥·抗發炎藥
  • 其他

第7章 全球品牌仿製藥市場:各類藥物

  • 市場概要:各類藥物
  • 市場趨勢,實際成果值·預測值
  • 各類藥物的市場分析
  • 烷化劑
  • 代謝拮抗劑
  • 荷爾蒙劑
  • 降壓藥
  • 脂質低墮胎藥
  • 抗憂鬱劑
  • 抗精神病藥
  • 抗癲癇藥
  • 其他

第8章 全球品牌仿製藥市場:各劑型類型

  • 市場概要:各劑型類型
  • 市場趨勢,實際成果值·預測值
  • 劑型類別的市場分析
  • 口服藥
  • 非口服藥
  • 外用製劑
  • 其他

第9章 全球品牌仿製藥市場:各流通管道

  • 市場概要:各流通管道
  • 市場趨勢,實際成果值·預測值
  • 各流通管道的市場分析
  • 醫院藥局
  • 零售藥局
  • 線上藥局
  • 藥妝店

第10章 全球品牌仿製藥市場:各地區

  • 各地區的未來展望
  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第11章 品牌仿製藥企業的競爭情形

  • 品牌仿製藥市場競爭狀態
  • 事業聯盟/合作,契約
  • 企業合併·收購 (M&A)
  • 新產品的銷售
  • 其他動向

第12章 企業簡介

  • 企業佔有率分析
  • 市場集中度
  • Teva
  • Abbott Laboratories
  • Novartis
  • Mylan
  • Pfizer
目錄
Product Code: VMR11216173

Value Market Research's latest report on the Global Branded Generics Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the forecast period of 2021-2027.

The global branded generics market report provides a complete evaluation of the market for the forecast period. The report consists of various segments as well as an analysis of the factors playing a significant role in the market. The factors include the drivers, restraints, challenges and opportunities and the impact of these factors on the market has been provided in the report. The drivers and restraints are classified as intrinsic factors while the opportunities and challenges are classified as extrinsic factors of the market. The global branded generics market study provides an insight on the developments of the market in terms of revenue throughout the specified period.

This report provides a complete analysis for the global branded generics market. An in-depth secondary research, primary interviews and in-house expert reviews are responsible for providing the market estimates for the global branded generics market. These market estimates have been put together by studying the impact of different social, political and economic factors along with the current market dynamics that are affecting the global branded generics market growth.

The report begins with the market overview, followed by a crisp executive summary. The Porter's Five Forces analysis covered in this study will assist in understanding the five forces namely buyers bargaining power, suppliers bargaining power, threat of new entrants, the threat of substitutes and the degree of competition in the global branded generics market. It also helps to explain the various participants such as system integrators, intermediaries and end users within the market. The report by Value Market Research also focuses on the competitive landscape of the global branded generics market.

The market analysis involves a section exclusively to list the major players of the global branded generics market wherein our analysts provide an insight into the financial statements of all the key players along with its key development product. The company profile section in the report also provides a business overview and financial information. The companies provided in this section can be customized as per the client's requirement.

The Branded Generics Market Report Segments the market as below:

By Therapeutic Application

  • Oncology
  • Cardiovascular Diseases
  • Diabetes
  • Neurology
  • Gastrointestinal Diseases
  • Dermatology Diseases
  • Analgesics and Anti-inflammatory
  • Others

By Drug Class

  • Alkylating Agents
  • Antimetabolites
  • Hormones
  • Anti-Hypertensive
  • Lipid Lowering Drugs
  • Anti-Depressants
  • Anti-Psychotics
  • Anti-Epileptics
  • Others

By Formulation Type

  • Oral
  • Parenteral
  • Topical
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . BRANDED GENERICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Therapeutic Application
    • 3.7.2 By Drug Class
    • 3.7.3 By Formulation Type
    • 3.7.4 By Distribution Channel
    • 3.7.5 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL BRANDED GENERICS MARKET ANALYSIS BY THERAPEUTIC APPLICATION

  • 6.1 Overview by Therapeutic Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Therapeutic Application
  • 6.4 Oncology Market by Regions
  • 6.5 Cardiovascular Diseases Market by Regions
  • 6.6 Diabetes Market by Regions
  • 6.7 Neurology Market by Regions
  • 6.8 Gastrointestinal Diseases Market by Regions
  • 6.9 Dermatology Diseases Market by Regions
  • 6.10. Analgesics and Anti-inflammatory Market by Regions
  • 6.11 Others Market by Regions

7 . GLOBAL BRANDED GENERICS MARKET ANALYSIS BY DRUG CLASS

  • 7.1 Overview by Drug Class
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Drug Class
  • 7.4 Alkylating Agents Market by Regions
  • 7.5 Antimetabolites Market by Regions
  • 7.6 Hormones Market by Regions
  • 7.7 Anti-Hypertensive Market by Regions
  • 7.8 Lipid Lowering Drugs Market by Regions
  • 7.9 Anti-Depressants Market by Regions
  • 7.10. Anti-Psychotics Market by Regions
  • 7.11 Anti-Epileptics Market by Regions
  • 7.12 Others Market by Regions

8 . GLOBAL BRANDED GENERICS MARKET ANALYSIS BY FORMULATION TYPE

  • 8.1 Overview by Formulation Type
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Formulation Type
  • 8.4 Oral Market by Regions
  • 8.5 Parenteral Market by Regions
  • 8.6 Topical Market by Regions
  • 8.7 Others Market by Regions

9 . GLOBAL BRANDED GENERICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 9.1 Overview by Distribution Channel
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Distribution Channel
  • 9.4 Hospital Pharmacies Market by Regions
  • 9.5 Retail Pharmacies Market by Regions
  • 9.6 Online Pharmacies Market by Regions
  • 9.7 Drug Stores Market by Regions

10 . GLOBAL BRANDED GENERICS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America
    • 10.3.1. Overview, Historic and Forecast Data
    • 10.3.2. North America By Segment
    • 10.3.3. North America By Country
    • 10.3.4. United State
    • 10.3.5. Canada
    • 10.3.6. Mexico
  • 10.4. Europe
    • 10.4.1. Overview, Historic and Forecast Data
    • 10.4.2. Europe by Segment
    • 10.4.3. Europe by Country
    • 10.4.4. United Kingdom
    • 10.4.5. France
    • 10.4.6. Germany
    • 10.4.7. Italy
    • 10.4.8. Russia
    • 10.4.9. Rest Of Europe
  • 10.5. Asia Pacific
    • 10.5.1. Overview, Historic and Forecast Data
    • 10.5.2. Asia Pacific by Segment
    • 10.5.3. Asia Pacific by Country
    • 10.5.4. China
    • 10.5.5. India
    • 10.5.6. Japan
    • 10.5.7. South Korea
    • 10.5.8. Australia
    • 10.5.9. Rest Of Asia Pacific
  • 10.6. Latin America
    • 10.6.1. Overview, Historic and Forecast Data
    • 10.6.2. Latin America by Segment
    • 10.6.3. Latin America by Country
    • 10.6.4. Brazil
    • 10.6.5. Argentina
    • 10.6.6. Peru
    • 10.6.7. Chile
    • 10.6.8. Rest of Latin America
  • 10.7. Middle East & Africa
    • 10.7.1. Overview, Historic and Forecast Data
    • 10.7.2. Middle East & Africa by Segment
    • 10.7.3. Middle East & Africa by Country
    • 10.7.4. Saudi Arabia
    • 10.7.5. UAE
    • 10.7.6. Israel
    • 10.7.7. South Africa
    • 10.7.8. Rest Of Middle East And Africa

11 . COMPETITIVE LANDSCAPE OF THE BRANDED GENERICS COMPANIES

  • 11.1. Branded Generics Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF BRANDED GENERICS INDUSTRY

  • 12.1. Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Teva
    • 12.3.1. Company Overview
    • 12.3.2. Financials
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Abbott Laboratories
    • 12.4.1. Company Overview
    • 12.4.2. Financials
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Novartis
    • 12.5.1. Company Overview
    • 12.5.2. Financials
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Mylan
    • 12.6.1. Company Overview
    • 12.6.2. Financials
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. Pfizer
    • 12.7.1. Company Overview
    • 12.7.2. Financials
    • 12.7.3. Products
    • 12.7.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Therapeutic Application (USD MN)
  • Oncology Market by Geography (USD MN)
  • Cardiovascular Diseases Market by Geography (USD MN)
  • Diabetes Market by Geography (USD MN)
  • Neurology Market by Geography (USD MN)
  • Gastrointestinal Diseases Market by Geography (USD MN)
  • Dermatology Diseases Market by Geography (USD MN)
  • Analgesics and Anti-inflammatory Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis Market by Drug Class (USD MN)
  • Alkylating Agents Market by Geography (USD MN)
  • Antimetabolites Market by Geography (USD MN)
  • Hormones Market by Geography (USD MN)
  • Anti-Hypertensive Market by Geography (USD MN)
  • Lipid Lowering Drugs Market by Geography (USD MN)
  • Anti-Depressants Market by Geography (USD MN)
  • Anti-Psychotics Market by Geography (USD MN)
  • Anti-Epileptics Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis by Formulation Type (USD MN)
  • Oral Market by Geography (USD MN)
  • Parenteral Market by Geography (USD MN)
  • Topical Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market by Geography (USD MN)
  • Retail Pharmacies Market by Geography (USD MN)
  • Online Pharmacies Market by Geography (USD MN)
  • Drug Stores Market by Geography (USD MN)
  • Global Branded Generics Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Branded Generics Report
  • Market Research Process
  • Market Research Methodology
  • Global Branded Generics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Therapeutic Application
  • Market Attractiveness Analysis by Drug Class
  • Market Attractiveness Analysis by Formulation Type
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Therapeutic Application (USD MN)
  • Oncology Market by Geography (USD MN)
  • Cardiovascular Diseases Market by Geography (USD MN)
  • Diabetes Market by Geography (USD MN)
  • Neurology Market by Geography (USD MN)
  • Gastrointestinal Diseases Market by Geography (USD MN)
  • Dermatology Diseases Market by Geography (USD MN)
  • Analgesics and Anti-inflammatory Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Drug Class (USD MN)
  • Alkylating Agents Market by Geography (USD MN)
  • Antimetabolites Market by Geography (USD MN)
  • Hormones Market by Geography (USD MN)
  • Anti-Hypertensive Market by Geography (USD MN)
  • Lipid Lowering Drugs Market by Geography (USD MN)
  • Anti-Depressants Market by Geography (USD MN)
  • Anti-Psychotics Market by Geography (USD MN)
  • Anti-Epileptics Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Formulation Type (USD MN)
  • Oral Market by Geography (USD MN)
  • Parenteral Market by Geography (USD MN)
  • Topical Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market by Geography (USD MN)
  • Retail Pharmacies Market by Geography (USD MN)
  • Online Pharmacies Market by Geography (USD MN)
  • Drug Stores Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.